<p>Thanks, UCB.</p>
<p>I’ve already downloaded the calculator and played around with it. Offhand, the only big change from the past calculator is that they no longer include a family (mother/father) history of early cardiovascular disease as a risk factor. It’s now based on age, gender, race, smoking status, blood pressure, and diabetes.</p>
<p>Basically:</p>
<p>1) Everyone between 40 and 70 with LDL of 190 should be sold a statin.</p>
<p>2) Everyone between 40 and 70 with cardiovascular disease or angina should be sold a statin, regardless of their LDL.</p>
<p>3) Everyone between 40 and 70 with diabetes should be sold a statin, regardless of their LDL.</p>
<p>4) Everyone else between 40 and 70 should use the calculator to see if they should be sold a statin.</p>
<p>I can confirm that my case a 59 year old white male non-smoker, with LDL of 100, blood pressure of 120, no diabetes, is not in the risk group high enough to be sold a statin. So I guess I can breath a sigh of relief! :)</p>
<hr>
<p>My initial reaction is that these guidelines surely don’t narrow the recommendations for statin sales. In the past, if you had coronary disease or diabetes and low LDL, they would not sell you a statin. Now, everyone in this risk groups gets sold a statin, regardless of their LDL. But, as a practical matter, that may not be a big difference as most of those people probably did not have super-low LDL. </p>
<p>I’m going to be curious to read the response of some of the critics, like Thomas Dayspring. It is pretty tough sledding to digest the guidelines. There is some stuff on strength of evidence and strength of recommendation that may be sending coded signals to the experts…</p>